Apollo Peptides
GLP-1 SM-10
GLP-1 SM-10
Couldn't load pickup availability
Overview
Semaglutide is a long-acting synthetic peptide analog of glucagon-like peptide-1 (GLP-1) that is studied exclusively in preclinical and in vitro research environments. It is derived from the incretin hormone GLP-1 and has been modified for enhanced stability and receptor affinity. Laboratory research on Semaglutide focuses on its interaction with GLP-1 receptors, peptide-receptor binding kinetics, and its role in glucose regulation and metabolic signaling models under non-human, controlled conditions.
Specifications
-
Unit Size: 10 mg per vial
-
Form: Lyophilized powder
-
Storage: Store dry at 2 °C–8 °C. After reconstitution, refrigerate at 2 °C–8 °C and use within 10–14 days.
-
Documentation: Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) available upon request.
Research Context
Preclinical and in vitro studies have examined Semaglutide in relation to:
-
GLP-1 receptor binding and downstream cAMP signaling pathways
-
Peptide stability and receptor selectivity modeling in metabolic assays
-
Cellular glucose regulation and bioenergetic response systems
-
Investigations of peptide-based incretin mimetics in laboratory settings
All information is derived from laboratory and non-human research. No claims are made regarding human safety, efficacy, or suitability for therapeutic use.
Intended Use / Restrictions
-
For laboratory research use only
-
Not for human or veterinary use
-
Not a drug, dietary supplement, or medical device
-
Buyer must be a qualified researcher or institution and assumes full responsibility for lawful handling and compliance with applicable laboratory regulations.
Important Notice
This product is provided strictly for scientific and educational purposes. The seller does not make any representations regarding its safety, effectiveness, or suitability for clinical or consumer applications. Semaglutide is not approved for human or veterinary administration. Proper storage, handling, and disposal must follow institutional biosafety procedures.
Share
